Journal of Pain & Palliative Care Pharmacotherapy
Overview
The Journal of Pain & Palliative Care Pharmacotherapy is a peer-reviewed publication dedicated to advancing the understanding and management of pain and palliative care through pharmacotherapy. It provides a platform for researchers, clinicians, and pharmacists to share their latest findings, innovations, and evidence-based practices in the field. The journal covers a wide range of topics, including pain management, symptom control, medication safety, and therapeutic interventions, with the ultimate goal of improving the quality of life for patients facing pain and end-of-life care.
Details
Details
Abbr.
J Pain Palliat Care Pharmacother
Publisher
Informa Healthcare
Start
2002
End
Continuing
Frequency
Quarterly
p-ISSN
1536-0288
e-ISSN
1536-0539
Country
United Kingdom
Language
English
Specialties
Pharmacology
Psychiatry
Critical Care
Psychiatry
Critical Care
Metrics
Metrics
h-index / Ranks: 7992
45
SJR / Ranks: 11069
355
CiteScore / Ranks: 12222
1.30
Recent Articles
1.
Waldfogel J, Herndon C
J Pain Palliat Care Pharmacother
. 2025 Mar;
38(4):322.
PMID: 40083209
No abstract available.
2.
Meyer-Junco L
J Pain Palliat Care Pharmacother
. 2025 Mar;
38(4):319-321.
PMID: 40083208
No abstract available.
3.
Bochnia Kuster J
J Pain Palliat Care Pharmacother
. 2025 Feb;
:1-2.
PMID: 39992872
No abstract available.
4.
Sams C, Cheng S
J Pain Palliat Care Pharmacother
. 2025 Feb;
:1-7.
PMID: 39976313
Treatment of chronic, non-cancer pain can be challenging in the presence of long-term opioid therapy (LTOT). Buprenorphine products can provide a unique option for chronic pain treatment due to the...
5.
Silva M, Linn K
J Pain Palliat Care Pharmacother
. 2025 Feb;
:1-4.
PMID: 39937618
Buprenorphine can be an effective and safe option for patients with chronic pain. We describe a case in which a patient on long-term full opioid agonists for chronic non-cancer pain...
6.
Barbieri M, Shah N, Iskra J, Field N, Gruver S
J Pain Palliat Care Pharmacother
. 2025 Feb;
:1-15.
PMID: 39937034
The purpose of this study was to better characterize morphine equivalent daily dose (MEDD) equivalencies with buccal buprenorphine, and identify real-world efficacy and safety outcomes associated with the use of...
7.
Varadpande M, Erridge S, Aggarwal A, Cowley I, Evans L, Clarke E, et al.
J Pain Palliat Care Pharmacother
. 2025 Feb;
:1-21.
PMID: 39921589
Cancer pain (CP) is a prevalent condition with limited pharmacotherapeutic options. Cannabis-based medicinal products (CBMPs) have shown analgesic effects, but their efficacy in CP remains contentious. This study aims to...
8.
Spargo A, Gonser L, Faley B
J Pain Palliat Care Pharmacother
. 2025 Feb;
:1-4.
PMID: 39901608
Naltrexone is an opioid antagonist approved by the Food and Drug Administration (FDA) for alcohol use disorder and opioid use disorder. More recently, naltrexone has been used off-label at low...
9.
Nasiri A, Mirhadi M, Nadgaran V, Motamedi A, Fakheri M
J Pain Palliat Care Pharmacother
. 2025 Jan;
1-11.
PMID: 39823237
This study compares the efficacy of hydrodilatation (HD) alone with intra-articular corticosteroid injection (ICI) in treating frozen shoulder (FS). A total of 48 patients with FS were randomly assigned to...
10.
Pingoliya S, Singhal Y
J Pain Palliat Care Pharmacother
. 2025 Jan;
:1-3.
PMID: 39745831
Mirtazapine is a selective serotonergic antidepressant that functions by blocking adrenergic alpha2-autoreceptors and heteroreceptors and inhibiting 5-HT2 and 5-HT3 receptors. It is a noradrenergic drug. Mirtazapine has anxiolytic or sleep-quality-improving...